Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation
NCT02991781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2020-02-17
Summary
This study will develop and experimentally test the efficiency of a neurofeedback training protocol vs. varenicline use for smoking cessation.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Smoking
Interventions
- OTHER
-
Biofeedback and Neurofeedback Training
The protocol will consist of 5 sessions of skin temperature biofeedback and 20 sessions of a neurofeedback training protocol that will consist of Alpha-Theta ratio up-training. The aim of the training is to reach a crossover state, were initially Alpha activity will increase and then in a deeper state, the Theta activity will take over. This state is associated with a reverie and disidentification with problems, stress or traumatic experiences. Therefore, the subjects will learn how to increase their Theta/Alpha ratio.
- DRUG
-
Varenicline use for smoking cessation
The protocol will consist 1 mg varenicline use twice daily following a 1-week titration for 3 months.
- OTHER
-
Sham Neurofeedback
Subjects will receive equal sessions of sham neurofeedback, and thus serve as a control group for the analysis and design of the study.
- OTHER
-
Passive Control
Subjects will not receive any intervention, but they will be measured via a clinical and psychometric evaluation with a time-difference of 3 months. This is equal to the intervention time. Hence, the subjects in this intervention type will serve as a control group for the analysis and design of the study.
Sponsors & Collaborators
-
AAI Scientific Cultural Services Ltd (AAISCS)
collaborator OTHER -
NATIONAL ASSOCIATION OF GENERAL PRACTITIONERS IN BULGARIA
collaborator UNKNOWN -
Aristotle University Of Thessaloniki
lead OTHER
Principal Investigators
-
Panos Bamidis, Ass. Prof · Medical School, Aristotle University of Thessaloniki
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-30
Countries
- Bulgaria
- Cyprus
- Greece
Study Locations
More Related Trials
-
Feasibility Study of Smoking Cessation for the Staff of a Hospital Center
NCT04635358 ·Status: COMPLETED ·Phase: NA
-
Brief Intervention Study for Quitting Smoking
NCT01589211 ·Status: TERMINATED ·Phase: NA
-
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
NCT04610931 ·Status: COMPLETED ·Phase: NA
-
Prevention of Smoking Related Diseases
NCT06451029 ·Status: RECRUITING
-
Effects of Smoking State on Decision Making
NCT04826276 ·Status: COMPLETED ·Phase: NA
-
Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
NCT06626178 ·Status: RECRUITING ·Phase: NA
-
Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes
NCT02301325 ·Status: COMPLETED ·Phase: NA
-
Biopsychosocial Predictors of Nicotine Relapse
NCT06470321 ·Status: RECRUITING ·Phase: NA
-
Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
NCT00865553 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology
NCT04172623 ·Status: COMPLETED ·Phase: NA
-
Cognitive and Emotional Skills to Aid Smoking Prevention
NCT03058991 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery
NCT04899492 ·Status: TERMINATED ·Phase: NA
-
Heart Rate Variability Biofeedback for Smoking Cessation Treatment
NCT05224050 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History of Attempts to Stop Smoking
NCT00995644 ·Status: COMPLETED
-
Cognitive Behaviour Therapy and Nicotine Replacement to Increase Tobacco Cessation
NCT01734330 ·Status: COMPLETED ·Phase: NA
-
Effect of Stress-management and Biofeedback on Craving in Smoking Abstinence: A Pilot Study
NCT01080092 ·Status: COMPLETED ·Phase: PHASE2
-
Heart Rate Variability Biofeedback for Smoking Cessation
NCT03972137 ·Status: COMPLETED ·Phase: PHASE2
-
Hospital-based Patient Navigation and Smoking Cessation
NCT03452371 ·Status: COMPLETED ·Phase: NA
-
Anxiety Sensitivity Program for Smoking Cessation
NCT00387049 ·Status: COMPLETED ·Phase: NA
-
Benefits of a Cognitive Behavioral Therapy Intervention for Smoking Cessation Supported by Virtual Reality Smoking Cue Exposure
NCT03707106 ·Status: COMPLETED ·Phase: NA
-
Use of a Smartphone Application (App) to Assist a Cognitive-Behavioral Smoking Cessation Treatment
NCT04765813 ·Status: COMPLETED ·Phase: NA
-
Couples Dynamics and Smoking Cessation
NCT03885336 ·Status: COMPLETED
-
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
NCT04965181 ·Status: COMPLETED ·Phase: NA
-
Combining Noninvasive Brain Stimulation and Cognitive Training on Tobacco Craving
NCT02810574 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
NCT02233842 ·Status: COMPLETED